Suchergebnisse - "Cantini, Fabrizio"

PubPharm (14)

1

Management of psoriatic arthritis : a consensus opinion by expert rheumatologists

enthalten in: Frontiers in medicine | 2023

von D'Angelo, S. | Atzeni, F. | Benucci, M. | +34

2

Mandatory, cost-driven switching from originator etanercept to its biosimilar SB4 : possible fallout on non-medical switching

enthalten in: Annals of the rheumatic diseases | 2020

von Cantini, F. | Benucci, M.

CommentOn: Ann Rheum Dis. 2019 Feb;78(2):192-200. - PMID 30396903

3

The impact of the interleukin 12/23 inhibitor ustekinumab on the risk of infections in patients with psoriatic arthritis

enthalten in: Expert opinion on drug safety | 2020

von Zabotti, A. | Goletti, D. | Lubrano, E. | +1

4

The impact of the interleukin 12/23 inhibitor ustekinumab on the risk of infections in patients with psoriatic arthritis

enthalten in: Expert opinion on drug safety | 2020

von Zabotti, A. | Goletti, D. | Lubrano, E. | +1

5

Biosimilars for the treatment of psoriatic arthritis

enthalten in: Expert review of clinical immunology | 2019

von Cantini, F. | Benucci, M. | Li Gobbi, F. | +2

6

Additional comment to : 'Switching from the bio-originators to biosimilar: is it premature to recommend this procedure?' by Scherlinger and Schaeverbeke

enthalten in: Annals of the rheumatic diseases | 2019

von Cantini, F. | Benucci, M.

CommentOn: Ann Rheum Dis. 2018 Feb;77(2):165-174. - PMID 28866648

7

Switching from the bio-originators to biosimilar : is it premature to recommend this procedure?

enthalten in: Annals of the rheumatic diseases | 2019

von Cantini, F. | Benucci, M.

CommentOn: Ann Rheum Dis. 2018 Feb;77(2):165-174. - PMID 28866648

8

Effectiveness of Adalimumab for the Treatment of Psoriatic Arthritis : An Italian Real-Life Retrospective Study

enthalten in: Frontiers in pharmacology | 2019

von D'Angelo, S. | Cantini, F. | Ramonda, R. | +29

9

Risk of malignancies using anti-TNF agents in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis : a systematic review and meta-analysis

enthalten in: Expert opinion on drug safety | 2016

von Bonovas, S. | Minozzi, S. | Lytras, T. | +13

10

Risk of infections using anti-TNF agents in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis : a systematic review and meta-analysis

enthalten in: Expert opinion on drug safety | 2016

von Minozzi, S. | Bonovas, S. | Lytras, T. | +14